Sirnaomics Announces Positive Topline Results from Interim Analysis of Ongoing Phase II Clinical Tri
Sirnaomics Inc.,a leading biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases,today announced topline results from the interim ···
Sirnaomics1432020-04-09